141 related articles for article (PubMed ID: 20415670)
1. Expression of p16 protein in acral lentiginous melanoma.
Hsieh R; Firmiano A; Sotto MN
Int J Dermatol; 2009 Dec; 48(12):1303-7. PubMed ID: 20415670
[TBL] [Abstract][Full Text] [Related]
2. Relationship between tumor-associated immune infiltrate and p16 staining over clinicopathological features in acral lentiginous melanoma.
Castaneda CA; Castillo M; Torres-Cabala C; Bernabe LA; Casavilca S; Villegas V; Sanchez J; de la Cruz M; Dunstan J; Cotrina JM; Gomez HL; Chavez C; Landa-Baella MP; Tello K; Felix BF; Abugattas J
Clin Transl Oncol; 2019 Sep; 21(9):1127-1134. PubMed ID: 30778854
[TBL] [Abstract][Full Text] [Related]
3. Acral lentiginous melanoma: Clinicopathologic and survival differences according to tumour location.
Howard M; Xie C; Wee E; Wolfe R; McLean C; Kelly JW; Pan Y
Australas J Dermatol; 2020 Nov; 61(4):312-317. PubMed ID: 32363586
[TBL] [Abstract][Full Text] [Related]
4. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions.
Demirkan NC; Kesen Z; Akdag B; Larue L; Delmas V
Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Melanocyte-Associated Immunohistochemical Markers in Acral Lentiginous Melanoma and Acral Benign Nevi.
Kim JC; Choi JW; Kim YC
Am J Dermatopathol; 2023 Nov; 45(11):748-752. PubMed ID: 37856738
[TBL] [Abstract][Full Text] [Related]
6. An analysis of p16 tumour suppressor gene expression in acral lentiginous melanoma.
Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO
Br J Plast Surg; 2000 Jan; 53(1):46-50. PubMed ID: 10657449
[TBL] [Abstract][Full Text] [Related]
7. Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage.
Talve L; Sauroja I; Collan Y; Punnonen K; Ekfors T
Int J Cancer; 1997 Jun; 74(3):255-9. PubMed ID: 9221801
[TBL] [Abstract][Full Text] [Related]
8. High density of M2-macrophages in acral lentiginous melanoma compared to superficial spreading melanoma.
Zúñiga-Castillo M; Pereira NV; Sotto MN
Histopathology; 2018 Jun; 72(7):1189-1198. PubMed ID: 29415335
[TBL] [Abstract][Full Text] [Related]
9. TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis.
Ramani NS; Aung PP; Gu J; Sfamenos S; Sdringola-Maranga C; Nagarajan P; Tetzlaff MT; Curry JL; Ivan D; Diab A; Prieto VG; Hwu WJ; Torres-Cabala CA
Mod Pathol; 2020 Oct; 33(10):2067-2074. PubMed ID: 32404956
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.
Coupland SE; Bechrakis N; Schüler A; Anagnostopoulos I; Hummel M; Bornfeld N; Stein H
Br J Ophthalmol; 1998 Aug; 82(8):961-70. PubMed ID: 9828785
[TBL] [Abstract][Full Text] [Related]
11. Loss of p16 expression is associated with histological features of melanoma invasion.
Pavey SJ; Cummings MC; Whiteman DC; Castellano M; Walsh MD; Gabrielli BG; Green A; Hayward NK
Melanoma Res; 2002 Dec; 12(6):539-47. PubMed ID: 12459643
[TBL] [Abstract][Full Text] [Related]
12. Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and p16 immunostaining in cutaneous melanomas.
Richmond-Sinclair NM; Lee E; Cummings MC; Williamson R; Muller K; Green AC; Hayward NK; Whiteman DC
Melanoma Res; 2008 Oct; 18(5):336-45. PubMed ID: 18781132
[TBL] [Abstract][Full Text] [Related]
13. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas.
de Sá BC; Fugimori ML; Ribeiro Kde C; Duprat Neto JP; Neves RI; Landman G
Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901
[TBL] [Abstract][Full Text] [Related]
14. Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors.
Karim RZ; Li W; Sanki A; Colman MH; Yang YH; Thompson JF; Scolyer RA
Int J Surg Pathol; 2009 Oct; 17(5):361-7. PubMed ID: 19666944
[TBL] [Abstract][Full Text] [Related]
15. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
Huang K; Fan J; Misra S
J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
[TBL] [Abstract][Full Text] [Related]
16. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
[TBL] [Abstract][Full Text] [Related]
17. The expression of human high molecular weight melanoma-associated antigen in acral lentiginous melanoma.
Nishi H; Inoue Y; Kageshita T; Takata M; Ihn H
Biosci Trends; 2010 Apr; 4(2):86-9. PubMed ID: 20448346
[TBL] [Abstract][Full Text] [Related]
18. Differential clinical significance of alpha(v)Beta(3) expression in primary lesions of acral lentiginous melanoma and of other melanoma histotypes.
Kageshita T; Hamby CV; Hirai S; Kimura T; Ono T; Ferrone S
Int J Cancer; 2000 Mar; 89(2):153-9. PubMed ID: 10754493
[TBL] [Abstract][Full Text] [Related]
19. Acral lentiginous melanoma: an immunohistochemical study of 20 cases.
Kim YC; Lee MG; Choe SW; Lee MC; Chung HG; Cho SH
Int J Dermatol; 2003 Feb; 42(2):123-9. PubMed ID: 12709000
[TBL] [Abstract][Full Text] [Related]
20. Acral lentiginous melanoma. A histological type without prognostic significance.
Cascinelli N; Zurrida S; Galimberti V; Bartoli C; Bufalino R; Del Prato I; Mascheroni L; Testori A; Clemente C
J Dermatol Surg Oncol; 1994 Dec; 20(12):817-22. PubMed ID: 7798414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
